Versor Investments’s Usana Health Sciences USNA Stock Holding History

Versor Investments’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,840	Closed	-$361K	–	921
2025 Q2	$361K	Sell	11,840 -1,160	-9%	-$32.9K	0.06%	486
2025 Q1	$351K	Buy	+13,000	New	+$412K	0.06%	517
2024 Q2	–	Sell	-6,307	Closed	-$306K	–	942
2024 Q1	$306K	Sell	6,307 -1,408	-18%	-$69K	0.06%	490
2023 Q4	$414K	Buy	7,715 +3,600	+87%	+$182K	0.08%	395
2023 Q3	$241K	Sell	4,115 -700	-15%	-$43.8K	0.05%	553
2023 Q2	$304K	Buy	4,815 +450	+10%	+$28.7K	0.05%	416
2023 Q1	$275K	Sell	4,365 -34	-0.8%	-$2.03K	0.04%	528
2022 Q4	$234K	Sell	4,399 -4,019	-48%	-$218K	0.02%	595
2022 Q3	$472K	Buy	+8,418	New	+$556K	0.03%	472

Other funds holding USNA

SWGC

Summit Wealth Group (Colorado) Colorado Springs, Colorado $950M AUM 24.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Versor Investments's USNA Position: Q3 2025 in Review

Versor Investments sold out of Usana Health Sciences (USNA) in Q3 2025, closing a stake of 11,840 shares — an estimated $361K sold.

Versor Investments first reported a position in USNA in Q3 2022 and held it in 9 quarters. The position peaked at $472K in Q3 2022. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.

Versor Investments reported no remaining Usana Health Sciences position as of Q3 2025 after selling out during the quarter.
Versor Investments sold 11,840 Usana Health Sciences shares in Q3 2025, an estimated $361K.
Versor Investments first reported a position in Usana Health Sciences in Q3 2022 and held it in 9 quarters.
Versor Investments's Usana Health Sciences position peaked at $472K in Q3 2022.
165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.